Glow-in-the-Dark dye could help surgeons spot hidden cancer in kids

NCT ID NCT07399821

Recruiting now Diagnosis Sponsor: Princess Maxima Center for Pediatric Oncology Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special dye called anti-GD2-800CW that makes neuroblastoma cells glow during surgery. About 22 children with neuroblastoma will receive a single dose of the dye before their operation. The goal is to find the safest and most effective dose to help surgeons see and remove all tumor tissue.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: anti-GD2-800CW (a fluorescent dye that attaches to neuroblastoma cells)
What this could lead to: If successful, this could help surgeons remove neuroblastoma tumors more completely during surgery by making cancer cells glow.
What could go wrong: This is an early-phase study with only 22 children, so the dye may not work as hoped or could cause side effects. It is not a treatment for the cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuroblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROBLASTOMA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Prinses Maxima Centrum
RECRUITING

Utrecht, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.